Fri, February 11, 2022

Cindy Motz Initiated (TDOC) at Strong Buy and Held Target at $121 on, Feb 11th, 2022

Cindy Motz of Goldman Sachs, Initiated "Teladoc Health, Inc." (TDOC) at Strong Buy and Held Target at $121 on, Feb 11th, 2022.

Cindy has made no other calls on TDOC in the last 4 months.



There are 13 other peers that have a rating on TDOC. Out of the 13 peers that are also analyzing TDOC, 5 agree with Cindy's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Glen Santangelo of "Jefferies" Maintained at Hold with Decreased Target to $82 on, Monday, February 7th, 2022
  • George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $81 on, Tuesday, January 25th, 2022
  • David Larsen of "BTIG" Downgraded from Strong Buy to Hold on, Monday, November 22nd, 2021
  • Scott Schoenhaus of "Stephens & Co." Maintained at Hold with Decreased Target to $135 on, Friday, November 19th, 2021
  • Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $150 on, Thursday, October 28th, 2021


These are the ratings of the 8 analyists that currently disagree with Cindy


  • Richard Close of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $160 on, Tuesday, November 23rd, 2021
  • Daniel Grosslight of "Citigroup" Maintained at Strong Buy with Decreased Target to $175 on, Friday, November 19th, 2021
  • Jailendra Singh of "Credit Suisse" Maintained at Buy with Decreased Target to $207 on, Friday, November 19th, 2021
  • Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $185 on, Friday, November 19th, 2021
  • Stephanie Davis of "SVB Leerink" Maintained at Buy with Decreased Target to $193 on, Friday, November 19th, 2021
  • Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $215 on, Monday, November 15th, 2021
  • Stephen Baxter of "Wells Fargo" Maintained at Buy with Increased Target to $165 on, Friday, October 29th, 2021
  • Ryan MacDonald of "Needham" Maintained at Strong Buy with Decreased Target to $170 on, Thursday, October 28th, 2021